Skip to content

The clinical observation of prevention hypotension after Anesthesia Induction of the olderly with hypertention by preload colloid and methoxamine

The clinical observation of prevention hypotension after Anesthesia Induction of the olderly with hypertention by preload colloid and methoxamine

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12001965
Enrollment
Unknown
Registered
2012-02-27
Start date
2011-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension After Induction of General Anesthesia

Interventions

methoxamine group:when anesthesia induced,preload methoxamine
ephedrine group:when anesthesia induced,preload ephedrine
NS group:when anesthesia induced, preload NS

Sponsors

Anesthesia department, Wuhan Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: ASA1-3, Elective surgery, general anesthesia, no cardiac surgery, age >=60; Hypertensive patients with baseline systolic blood pressure<=180mmHg or baseline diastolic blood pressure<=110mmHg; Sign the ICF, voluntary to paticipate and could coordinate.

Exclusion criteria

Exclusion criteria: Allergic to methoxamine and ephedrine; ASA>=4; With serious cardiovascular disease, NYHA>=3; Nearly six months have cerebrovascular accident, myocardial infarction; Malignant arrhythmia; Coronary heart disease patients; Serious valve disease; Serious systemic chronic disease (such as hyperthyroidism, copd, diabetes) without good control; Badly damaged liver and kidney function (Tbil > 1.5 ULN, ALT > 2 ULN or AST, Cr > 1 ULN); Have serious electrolytes disturbance; Moderate to severe anemia patients (Hb < 90 g/L); Basic heart rate < 50 / minutes; With Secondary high blood pressure; Intubation time more than 60 seconds; Pregnancy or lactation women; Participate other clinical drug test during nearly 3 months.

Design outcomes

Primary

MeasureTime frame
blood pressure;CI/C;

Secondary

MeasureTime frame
heart rate;

Countries

China

Contacts

Public ContactQingping Wu
wu_qingping1968@yahoo.com.cn+86 13971605283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026